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Abstract
Background: Diffuse renal and retroperitoneal metastasis of prostatic origin is an uncommon spread pattern of
prostate cancer.
Case presentation: We described a 74-year-old male patient who was admitted because of dysuria and nocturia.
Physical examination and imaging study indicated prostate mass, and laboratory analysis revealed elevated prostate
specific antigen (PSA). The diagnosis of prostate cancer was established after biopsy. In the further evaluation, diffuse
renal and retroperitoneal metastasis of prostate cancer was confirmed. Radiotherapy combined with endocrine therapy
was given.
Conclusions: Our present case emphasized that the routine metastatic work-up was quite necessary, since a small
proportion of men with advanced prostate cancer might experience metastases in atypical sites.
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Background
Renal and retroperitoneal metastasis from prostatic ori-
gin is an extremely rare clinical entity. Although prostate
cancer has a recognizable pattern of spread, most often
to regional lymph nodes and to the skeleton [1], many
patients might present with atypical metastases at diag-
nosis [2]. We present a 74-year-old man who had a his-
tory of abnormally elevated prostate specific antigen
(PSA) level. Radiological study suggested that the patient
had diffuse retroperitoneal abnormal tissue and masses
in the left kidney, which was confirmed to be metastasis
from prostate cancer by biopsy. Renal and retroperiton-
eal metastasis from prostate cancer is a rare clinical en-
tity. Necessary examination should be taken to make
correct diagnosis.
Case presentation
A 74-year-old male patient with 2-month history of dys-
uria and nocturia came to our hospital. Physical examin-
ation revealed mild edema of lower extremities. A hard
nodule in the right lobe of prostate was detected in digit
rectal exam. Laboratory data suggested an elevated PSA
level of 36.801 μg/L. Prostate magnetic resonance
imaging indicated that there was a solid mass in the
right peripheral lobe of prostate with extracapsular ex-
tension and seminal vesicle invasion. The histological
diagnosis of prostate cancer with Gleason score 5 + 4 = 9
was established by prostate biopsy.
In the further evaluation, skeleton scan was non-
significant, but the ultrasonography found that there was
a low echogenic mass in the upper pole of the left kid-
ney. For further investigation, computed tomography
(CT) was taken. The CT scan showed diffuse retroperi-
toneal low density mass wrapping the aorta and renal
pedicle along with the left upper pole renal tumor
(Fig. 1), which indicated the possibility of lymphoma. So
the ultrasonography-guided retroperitoneal and renal
mass biopsy was performed. The pathology (Fig. 2) sug-
gested that the mass was adenocarcinoma, which was
considered to be originating from the prostate according
to the immunohistochemical stain. Considering the fea-
ture of metastatic prostate cancer, radiotherapy com-
bined with endocrine therapy was given. However, the
patient abandoned the treatment 1 month later because
of economic reason and was lost in the follow-up.
Discussion
Prostate cancer is the second most commonly diagnosed
malignancy in men in the Western world and the second
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leading cause of cancer-related deaths among men
worldwide [3]. Most prostate-cancer-related deaths re-
sult from distant metastasis [4]. The location of the
metastatic lesion is not random, prostate cancer tends to
spread to the skeleton [5]. Less frequently, it spreads to
the liver, lung, bladder, or brain. Giorgio et al. [6] sum-
marized 74,826 patients with metastatic prostate cancer
from 1998 to 2010. They reported the most common
metastatic sites were the bone (84 %), distant lymph
nodes (10.6 %), liver (10.2 %), and thorax (9.1 %). Pros-
tate cancer metastasis proceeds through a complex
series of molecular events that include angiogenesis at
the site of the original tumor, local migration within the
primary site, intravasation into the blood stream, sur-
vival within the circulation, extravasation of the tumor
cells to the target organ, and colonization of those cells
within the new site [5].
Retroperitoneal involvement is an uncommon mani-
festation of prostate cancer. It is usually results from
lymphatic spread of nodal metastases in ascending pat-
tern. Metastases to the kidney are even more rare. To
the best of our knowledge from literature searches, there
are very few literatures that reported on renal metastasis
from prostatic cancer. Philip et al. [7] reported a patient
who was managed as a case of infected renal cyst which
later turned out to be a metastatic prostatic adenocar-
cinoma with a rare pattern of widespread bony metasta-
ses. The authors suggested that suspicion was needed in
order to avoid potential diagnostic pitfall. Fahd et al. [8]
also reported a case with a left-sided renal mass found
by radiological study. Subsequent histological examination
and immunostain of biopsied tissue revealed feature char-
acteristics of metastatic moderately differentiated to a fo-
cally poorly differentiated, large duct type of prostatic
adenocarcinoma.
In our case, we also found the left kidney lesion inci-
dentally. But unlike the previous two cases, the retro-
peritoneal space of our current patient was diffusely
invaded by the metastatic lesion, which could possibly
mislead to the diagnosis of lymphoma. Biopsy helped us
establish the correct diagnosis. So we should bear in
mind that although the skeleton is the most common
Fig. 1 Computed tomography. a The arterial phase scanning image showing diffuse retroperitoneal mass wrapping the aorta and renal pedicle
(arrow head), especially the left renal artery. b The excretory phase image showing the tumor (arrow head) located on the upper pole of the left
kidney. c Coronal image revealed retroperitoneal mass with renal involvement (arrow)
Fig. 2 Histopathologic examination of renal and prostate biopsy. a Microscopic image revealed both renal metastases (arrow) and extra-capsular
(asterisk) cancer tissue. b Microscopic appearance of retroperitoneal cancer with renal capsule (arrow) involvement. (H&E stain, ×100). b Retroperitoneal
cancer with muscle (arrow) invasion. (H&E stain, ×100). c Prostate biopsy tissue (H&E stain, ×400)
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site of prostate cancer metastasis, a small proportion of
men with advanced prostate cancer might experience
metastases in atypical sites. Thus, routine metastatic
work-up was quite necessary.
Conclusions
Metastasis work-up was quite necessary to rule-out extra-
skeleton metastasis for those with high-risk prostate can-
cer, as a small proportion of patients with advanced dis-
ease would suffer from atypical site metastasis.
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